See more : Rawasi Albina Investment Co. (9547.SR) Income Statement Analysis – Financial Results
Complete financial analysis of Surgical Science Sweden AB (publ) (SUSRF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Surgical Science Sweden AB (publ), a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Companhia Paranaense de Energia – COPEL (CPLE11.SA) Income Statement Analysis – Financial Results
- Venator Materials PLC (VNTR) Income Statement Analysis – Financial Results
- Canadian Net Real Estate Investment Trust (CNNRF) Income Statement Analysis – Financial Results
- Big Camera Corporation Public Company Limited (BIG.BK) Income Statement Analysis – Financial Results
- Samart Digital Public Company Limited (SDC.BK) Income Statement Analysis – Financial Results
Surgical Science Sweden AB (publ) (SUSRF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.surgicalscience.com
About Surgical Science Sweden AB (publ)
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 882.85M | 802.54M | 366.78M | 104.80M | 101.52M | 65.70M | 57.98M | 51.80M | 46.10M | 41.10M |
| Cost of Revenue | 269.97M | 271.02M | 100.84M | 16.44M | 17.94M | -6.22M | -4.14M | -6.30M | -6.30M | 18.17M |
| Gross Profit | 612.88M | 531.52M | 265.94M | 88.36M | 83.58M | 71.92M | 62.12M | 58.10M | 52.40M | 22.93M |
| Gross Profit Ratio | 69.42% | 66.23% | 72.51% | 84.32% | 82.33% | 109.47% | 107.15% | 112.16% | 113.67% | 55.79% |
| Research & Development | 181.65M | 172.79M | 65.71M | 16.57M | 16.95M | 13.74M | 8.35M | 7.80M | 5.92M | 4.06M |
| General & Administrative | 72.51M | 63.65M | 66.04M | 13.77M | 12.70M | 33.76M | 30.69M | 28.90M | 23.70M | 0.00 |
| Selling & Marketing | 167.51M | 138.22M | 79.92M | 36.66M | 38.09M | 30.71M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 240.02M | 201.88M | 145.96M | 50.43M | 50.79M | 33.76M | 30.69M | 28.90M | 23.70M | 20.89M |
| Other Expenses | 2.06M | -5.68M | -2.25M | 1.39M | 666.00K | 42.23M | 35.17M | 29.50M | 27.00M | 0.00 |
| Operating Expenses | 423.73M | 368.98M | 209.42M | 68.39M | 68.40M | 75.99M | 65.85M | 58.40M | 50.70M | 25.88M |
| Cost & Expenses | 693.70M | 640.00M | 310.26M | 84.83M | 86.34M | 69.77M | 61.71M | 52.10M | 44.40M | 44.05M |
| Interest Income | 64.73M | 65.12M | 32.23M | 217.00K | 71.00K | 4.00K | 3.00K | 1.00K | 0.00 | 90.28K |
| Interest Expense | 656.00K | 1.31M | 22.95M | 315.00K | 0.00 | 7.00K | 179.00K | 200.00K | 200.00K | 0.00 |
| Depreciation & Amortization | 23.00M | 43.64M | 26.30M | 10.25M | 15.19M | 2.12M | 2.12M | 8.81M | 7.10M | 4.98M |
| EBITDA | 214.29M | 271.30M | 115.05M | 30.22M | 30.37M | -1.95M | -2.25M | 8.59M | 8.90M | 2.04M |
| EBITDA Ratio | 24.27% | 32.53% | 33.34% | 35.26% | 29.91% | 9.22% | 11.92% | 16.41% | 19.31% | 4.96% |
| Operating Income | 189.15M | 162.54M | 88.75M | 19.97M | 15.18M | -4.07M | -3.74M | -200.00K | 1.80M | -2.95M |
| Operating Income Ratio | 21.43% | 20.25% | 24.20% | 19.06% | 14.95% | -6.19% | -6.44% | -0.39% | 3.90% | -7.17% |
| Total Other Income/Expenses | 79.11M | 45.64M | -22.95M | -315.00K | 71.00K | -3.00K | -176.00K | -242.00K | -176.62K | -90.28K |
| Income Before Tax | 268.26M | 208.17M | 65.80M | 19.66M | 15.25M | -4.07M | -3.91M | -500.00K | 1.60M | -3.04M |
| Income Before Tax Ratio | 30.39% | 25.94% | 17.94% | 18.76% | 15.02% | -6.20% | -6.75% | -0.97% | 3.47% | -7.39% |
| Income Tax Expense | 34.29M | 20.20M | -20.44M | 4.05M | 2.65M | 447.00K | -1.65M | -3.70M | 100.00K | 0.00 |
| Net Income | 233.97M | 187.97M | 86.25M | 15.61M | 12.60M | -4.52M | -2.26M | 3.30M | 1.60M | -3.04M |
| Net Income Ratio | 26.50% | 23.42% | 23.52% | 14.89% | 12.41% | -6.88% | -3.89% | 6.37% | 3.47% | -7.39% |
| EPS | 4.59 | 3.70 | 2.03 | 0.45 | 0.45 | -0.19 | -0.12 | 0.23 | 0.07 | -0.21 |
| EPS Diluted | 4.59 | 3.69 | 2.02 | 0.45 | 0.43 | -0.18 | -0.12 | 0.23 | 0.07 | -0.21 |
| Weighted Avg Shares Out | 50.97M | 50.80M | 42.49M | 34.37M | 28.20M | 24.32M | 19.32M | 14.32M | 24.32M | 14.32M |
| Weighted Avg Shares Out (Dil) | 50.94M | 50.91M | 42.67M | 34.37M | 29.05M | 24.68M | 19.60M | 14.32M | 24.32M | 14.32M |
Source: https://incomestatements.info
Category: Stock Reports